QR-Code

Low Neutralizing Antibody Titers against the Mu Variant of SARS-CoV-2 in 31 BNT162b2 Vaccinated Individuals in Colombia

Global surveillance programs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are showing the emergence of variants with mutations in the spike protein. Genomic and laboratory surveillance are important to determine if these variants may be more infectious or less susceptible to anti...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Diego A. Álvarez-Díaz, Ana Luisa Muñoz, Pilar Tavera-Rodríguez, María T. Herrera-Sepúlveda, Hector Alejandro Ruiz-Moreno, Katherine Laiton-Donato, Carlos Franco-Muñoz, Dioselina Pelaez-Carvajal, Diego Cuellar, Alejandra M. Muñoz-Suarez, Marisol Galindo, Edgar J. Arias-Ramírez, Marcela Mercado-Reyes
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI AG 2022-01-01
Schriftenreihe:Vaccines
Schlagworte:
COVID-19
spike protein
SARS-CoV-2 variants
neutralizing antibodies
Mu (B.1.621) variant
gamma (P.1) variant
Online-Zugang:https://www.mdpi.com/2076-393X/10/2/180
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge